Stocks · News reference

enGene Therapeutics Announces Virtual Key Opinion Leader Event On August 11 Covering NMIBC Treatment Landscape, Sequencing, Pricing And Reimbursement Dynamics

Aug 4, 2026, 12:06 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaJul 16, 2026, 12:12 PMBenzinga Newsdesk
EnGene Therapeutics Appoints Michael Heffernan Board Chairman, Effective Immediately, Succeeding Richard Glickman
enGene Therapeutics Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced changes to its Board of Directors as it plans for potential
Read original at benzinga
ENGN
BenzingaJun 18, 2026, 12:10 PMAvi Kapoor
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Wall Street analysts updated ratings for CURB, INTU, ENGN. See their outlooks and targets at Benzinga's analyst ratings page.
Read original at benzinga
CEG CURB ENGN IMMX INTU
BenzingaJun 16, 2026, 12:26 PMAvi Kapoor
W.P. Carey To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday
Top analysts changed ratings on top names, including Sunrun, enGene Therapeutics, Camp4 Therapeutics, PennyMac Financial, Dave & Buster's, Neumora Therapeutics, Extra Space Storage, & W. P. Carey. See full list here.
Read original at benzinga
AMGN CAMP ENGN EXR NMRA